Todd Zavodnick, Dermavant CEO

Der­ma­vant says Vta­ma top­i­cal cream works in PhI­II eczema tri­al

Der­ma­vant Sci­ences said its plaque pso­ri­a­sis-ap­proved cream Vta­ma al­so worked in pa­tients with atopic der­mati­tis, as the Roivant sub­sidiary push­es to­ward a la­bel ex­pan­sion of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.